4FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. Hafner C, Di Martino E,.Exp Cell Res. 2010 Jul 15;316(12):2008-16.
5The expression of GLTSCR2, a candidate tumor suppressor, is reduced in seb- orrheic keratosis compared to normal skin. Kim JY, Kim HS, Lee S, Park JH. Pathol Res Pract. 2010 May 15;206(5):295-9.
6Cllnical evaluation of prevalence of seborrheic keratosis of face and neck skin among oncological patients Lebedeva IuV, Davydov AB, Lebedev SN.Stoma- tologiia (Mosk). 2009;88(5):45-8. Russian.
7Seborrheic keratosis that follows Blaschko's lines. Mabuchi T, Akasaka E, Kondoh A, Umezawa Y, Matsuyama T, Ozawa A.J Dermatol. 2008 May;35 (5): 301-3.
8Aheration of p53-binding protein 1 expression during skin carcinogenesis: as- sociation with genomic instability.Naruke Y, Nakashima M, Suzuki K, Matsuu- Matsuyama M, Shichijo K, Kondo H, Sekine I.Cancer Sci. 2008 May;99 (5):946- 51.
9Use of a keratolytic agent with occlusion for topical treatment of hyperkeratotic seborrheic keratoses.Burkhart CG, Burkhart CN.Skinmed. 2008 Jan-Feb;7(1):15- 8.
10Eruptive seborrhoeic keratoses associated with erythrodermic pttyriasis rubra pilaris,Gleeson CM, Chan I, Grifllths WA, Bunker CB.J Eur Acad Dermatol Vene, reol. 2009 Feb;23(2):217-8.
